CTSA Groups and Meetings
CTSA Program groups and committees execute the recommendations of the NCATS Advisory Council Working Group and encourage collaboration within the CTSA Program. The objectives of each group and committee include meeting both short- and long-term needs to provide patients with access to treatments more quickly through translational science, providing a structure where measurable objectives can support the strategic goals of the CTSA Program, advocating for inclusivity by allowing all CTSA Hubs and their members to have equal access to resources, and fostering a collaborative group dynamic with discrete objectives, timelines, and deliverables for each activity. Learn about the different types of groups and committees below.
Enterprise Committees play a vital role in advancing clinical and translational science by focusing on high-priority areas as designated by NCATS. These committees engage in a range of activities to achieve CTSA Program objectives, including promoting collaboration and innovation, creating a space for discussion, and disseminating best practices. In addition to these activities, the Enterprise Committees may develop plans for projects that fill gaps and further program objectives.Learn More
Working Groups are designed to address specific clinical and translational science issues. The members of each working group are responsible for proposing and delivering well-defined deliverables that fill identified translational science gaps and further the CTSA Program objectives in high priority areas. CCOS provides simultaneous support for up to 12 active working groups.Learn More
The Consortium Groups bring together individuals with specialized skills and experience from different CTSA hubs to collaborate and share insights across the consortium. These groups include Communicators, Administrators, KL2 PI/Directors, and TL1 PI/Directors.Learn More
What are Enterprise Committees, and what is their purpose?
Enterprise Committees are groups that focus on high priority areas in clinical and translational science, with the aim of advancing CTSA Program objectives.
How many Working Groups can an Enterprise Committee have?
Enterprise Committees may propose any number of Working Groups, but the Steering Committee can approve a maximum of 12 Working Groups at any time. The Steering Committee also supports and approves Working Groups in all areas of clinical and translational science, with a limit of two Working Groups from any specific Enterprise Committee.
How do Enterprise Committees and Working Groups relate to each other?
Working Groups are one way that Enterprise Committees can carry out projects to achieve program objectives and fill identified gaps.
Who can join an Enterprise Committee?
Each CTSA Program hub is required to have membership of at least one Enterprise Committee.
How can the Steering Committee Co-chair be retained on the lead team for the Enterprise Committees?
The Steering Committee Co-chair must be nominated by themselves or others to be on the lead team of the Enterprise Committee and go through the election process. The Enterprise Committee lead team can choose to make them the chair or co-chair of the EC, but they will not serve as a Steering Committee member for any Working Groups originating from their Enterprise Committee due to conflict of interest.
Which lead team decides who will be chair and co-chair, if the team decides there needs to be a co-chair?
The incoming lead team for the Enterprise Committee will decide who will be the chair or co-chair for the coming year.
What is the process for electing the Lead Team for the Enterprise Committee?
Please refer to the CTSA Program Groups Guidance document for clarification.
Can a hub have more than one voting member on an Enterprise Committee?
No, each hub can only have one voting member on an Enterprise Committee.
How will information from Enterprise Committees reach the Steering Committee when there is no Steering Committee representation in the Enterprise Committee?
Enterprise Committees report annually to the Steering Committee via a teleconference meeting. Enterprise Committees will report annually to the Consortium through a CTSA Program Webinar and hold an annual face-to-face meeting.
What are Working Groups?
Working Groups are groups that focus on developing solutions for specific clinical and translational science issues. They propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high priority areas in clinical and translational science.
Who can join a Working Group?
Anyone in the CTSA Program and a limited number of community members (See CTSA Program Groups Guidance document.)
Who can submit an application for a Working Group?
Most members of the CTSA Program want to propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high priority areas in clinical and translational science. For example, Working Group proposals may be submitted by DF members, hub or pod members, or consortium committees. CD2H and TIN are not allowed to propose WGs through this process, as they have other available resources.
What is the maximum timeframe a Working Group has to meet its deliverables?
The maximum timeframe is 2 years. Requests for additional time require Steering Committee review and may result in transition to a discussion forum.
What happens to all content once a Working Group sunsets?
All content will be archived, and requests may be made to access the information.